Abstract Library

#4593 Excellent response to Ac-225 DOTATATE therapy in a patient with small cell lung cancer

Introduction: Peptide receptor radionuclide therapy (PRRT) is a validated treatment for patients with NETs overexpressing somatostatin receptors (SSTR). IHC analysis indicates that up to 50% of small cell lung cancer (SCLC) tumours are SSTR2 positive and thus can be targeted by SSR imaging and PRRT. Therapy with α-emitting radionuclides, such as Ac225, may offer several advantages over β-emitters by having higher energy transfer and more effective cancer cell death.

Conference:

Presenting Author: Tuncel M

Authors: Tuncel M, Türkan C, Eryılmaz Y, Pala A, Kılıçkap S,

Keywords: Ac-225 DOTATATE, Small Cell lung cancer, PET, somatostatin receptor, PRRT,

#1682 Clinicohistopathological Features and Treatment Outcomes of Neuroendocrine Tumors; A Single Center Experience

Introduction: Neuroendocrine tumors (NETs) are very heterogeneous family of cancers.Tumor and patient characteristics of NETs significantly change between geographical locations that probably induced by environmental and genetic factors throughout the world. Therefore, reporting single center experience may help to clarify epidemiological view and to improve the decision-making process.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Sumbul A

Authors: Sumbul A, Sedef A, Kose F, Mertsoylu H, Sezer A,

Keywords: Neuroendocrine tumors, single center,

#914 French Cohort of Familial Midgut Carcinoid Tumors

Introduction: Familial Midgut Carcinoid Tumors (FMCT) are a rare and poorly described entity defined by the occurrence of a midgut carcinoid tumor in at least two first-degree relatives.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: de Mestier L

Authors: De Mestier L, Fleury C, Pasmant E, Brixi H, Murat A,

Keywords: carcinoid tumor, family, heredity ,

#199 Magnetic Resonance Imaging (MRI) v. Endoscopic Ultrasonography (EUS) for the Detection of =10-mm Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1 (MEN1). A GTE Study

Introduction: In MEN1, the main risk factor of metastases is pancreatic tumor size. We and others recommend limiting surgery to pancreatic tumors >20 mm or growing based on their size measured with EUS.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Barbe C, Murat A, Dupas B, Ruszniewski P, Tabarin A,

Keywords: MEN 1, pancreas, endoscopic ultrasonography, magnetic resonance imaging, metastases,

#58 Surgical approaches in 84 patients with insulinomas in multiple endocrine neoplasia type 1 (MEN 1)

Introduction: Management of insulinomas in the setting of Multiple Endocrine Neoplasia type 1 (MEN1) remains controversial.

Conference: 7th Annual ENETSConcerence (2010)

Presenting Author: Baudin E

Authors: Vezzosi D, Cardot-Bauters C, Murat A, Bertholon-Gregoire M, Niccoli P,

Keywords: insulinoma, multiple endocrine neoplasia type 1, enucleation, cephalic duodenopancreatectomy, splenopancreatectomy, total pancreatectomy,